Milestone Pharmaceuticals MIST
NASDAQ MIST
$0.66 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Milestone Pharmaceuticals (MIST) Current Deferred Revenue (2026)

Updated

Milestone Pharmaceuticals (MIST) posted Current Deferred Revenue of $1.03 million for Q2 2026, up 148.6% from the prior quarter.

Analysis

Milestone Pharmaceuticals (MIST) Current Deferred Revenue (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Milestone Pharmaceuticals 82.17 Mn -88.43 Mn 527,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.03 Mn
Mar 31, 2026 416,000.00
API Access

Milestone Pharmaceuticals Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=MIST&period=max&api_key=YOUR_API_KEY